Brivanib Alaninate (BMS-582664) Chemical Structure
BMS-582664, also named “brivanib alaninate”, is the alaninate salt of a VEGFR2 inhibitor BMS-540215. Brivanib is hydrolyzed to the active moiety BMS-540215 in vivo. BMS-540215 shows potent and selective inhibition of VEGFR and FGFR tyrosine kinases [1,2] . BMS-540215 is an ATP-competitive inhibitor of human VEGFR-2, with an IC50 of 25 nM and Ki of 26 nmol/L. In addition, it inhibits VEGFR-1 (IC50 =380nM) and VEGFR-3 (IC50 = 10 nM). BMS-540215 also showed good selectivity for FGFR-1 (IC50=148 nM), FGFR-2 (IC50 =125 nM), and FGFR-3 (IC50 = 68 nM). Furthermore,BMS-540215 has been shown to selectively inhibit the proliferation of endothelial cells stimulated by VEGF and FGF in vitro with IC50 values of 40 and 276 nM, respectively[3,4] .
BMS-582664 was prepared in an effort to improve the aqueous solubility and oral bioavailability of the parent compound BMS-540215.
 Clin Cancer Res 2008;14:6146-6153
 J. Med. Chem 2008;51:1976–1980
 Cancer Res 2007;67:6899-6906
 Journal of Medicinal Chemistry April 6, 2006;49:2143-2146
|Molecular Weight (WM):||441.46|
A collection of 1159 inhibitors
A collection of 271 kinase inhibitors
A collection of 853 FDA approved drugs
A collection of 144 natural products
A collection of 1650 bioactive compounds
A collection of 118 tyrosine kinase inhibitors
Data independently produced by Dr. Yong-Weon Yi from Georgetown University Medical Center Brivanib Alaninate (BMS-582664) purchased from Selleck
Keywords:buy Brivanib Alaninate (BMS-582664) | Brivanib Alaninate (BMS-582664) supplier | purchase Brivanib Alaninate (BMS-582664) | Brivanib Alaninate (BMS-582664) cost | Brivanib Alaninate (BMS-582664) manufacturer | order Brivanib Alaninate (BMS-582664) | Brivanib Alaninate (BMS-582664) distributor